Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 5:05 pm Purchase | 2026-06-30 | 13G | HEMAB THERAPEUTICS HLDGS INC C COAG | Novo Holdings A/S | 4,180,550 9.000% | 4,180,550 (New Position) | Filing History |
| 2026-08-14 5:03 pm Purchase | 2026-06-30 | 13G | AVALYN PHARMA INC AVLN | Novo Holdings A/S | 3,883,289 8.800% | 3,883,289 (New Position) | Filing History |
| 2026-08-10 4:21 pm Purchase | 2026-08-03 | 13G | OBSIDIAN THERAPEUTICS, INC. OBX | Novo Holdings A/S | 3,123,992 5.100% | 3,123,992 (New Position) | Filing History |
| 2026-07-31 09:25 am Sale | 2026-07-30 | 13D | MAPLIGHT THERAPEUTICS INC MPLT | Novo Holdings A/S | 2,086,622 4.900% | -1,600,000 (-43.40%) | Filing History |
| 2026-05-15 4:28 pm Unchanged | 2026-03-31 | 13G | LANZATECH GLOBAL, INC. LNZA | Novo Holdings A/S | 158,148 1.600% | 0 (Unchanged) | Filing History |
| 2026-04-27 4:49 pm Sale | 2026-04-23 | 13D | EDGEWISE THERAPEUTICS INC EWTX | Novo Holdings A/S | 5,350,000 4.900% | -199,900 (-3.60%) | Filing History |
| 2026-02-17 6:55 pm Purchase | 2025-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | Novo Holdings A/S | 3,650,737 6.400% | 475,737 (+14.98%) | Filing History |
| 2026-02-17 6:54 pm Sale | 2025-12-31 | 13G | EVOTEC SE AMERICAN DEPOSITARY EVO | Novo Holdings A/S | 0 0.000% | -9,407,883 (Position Closed) | Filing History |
| 2026-01-23 7:05 pm Sale | 2026-01-21 | 13D | IO BIOTECH INC IOBTQ | Novo Holdings A/S | 2,469,135 3.300% | -2,512,453 (-50.43%) | Filing History |
| 2025-11-14 6:30 pm Sale | 2025-09-30 | 13G | EVOTEC SE AMERICAN DEPOSITARY EVO | Novo Holdings A/S | 9,407,883 5.300% | -5,523,975 (-36.99%) | Filing History |
| 2025-11-14 6:29 pm Sale | 2025-09-30 | 13G | ZENAS BIOPHARMA INC ZBIO | Novo Holdings A/S | 2,000,000 4.700% | -214,967 (-9.71%) | Filing History |
| 2025-11-04 4:21 pm Purchase | 2025-10-28 | 13D | MAPLIGHT THERAPEUTICS INC MPLT | Novo Holdings A/S | 3,686,622 8.400% | 3,686,622 (New Position) | Filing History |
| 2025-10-20 5:12 pm Purchase | 2025-10-13 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | Novo Holdings A/S | 3,175,000 6.800% | 3,175,000 (New Position) | Filing History |
| 2025-10-09 4:29 pm Sale | 2025-10-07 | 13D | GALECTO INC GLTO | Novo Holdings A/S | 0 0.000% | -86,579 (Position Closed) | Filing History |
| 2025-09-25 4:49 pm Sale | 2025-09-23 | 13D | GALECTO INC GLTO | Novo Holdings A/S | 86,579 6.500% | -13,334 (-13.35%) | Filing History |
| 2025-08-19 5:09 pm Sale | 2025-08-11 | 13D | IO BIOTECH INC IOBTQ | Novo Holdings A/S | 4,981,588 7.300% | -841,996 (-14.46%) | Filing History |
| 2025-08-14 4:59 pm Purchase | 2025-06-30 | 13G | ARRIVENT BIOPHARMA INC AVBP | Novo Holdings A/S | 1,872,142 4.900% | 122,142 (+6.98%) | Filing History |
| 2025-04-01 9:47 pm Purchase | 2025-03-25 | 13G | ZENAS BIOPHARMA INC ZBIO | Novo Holdings A/S | 2,214,967 5.300% | 2,214,967 (New Position) | Filing History |
| 2025-02-14 9:00 pm Purchase | 2025-02-07 | 13G | ARRIVENT BIOPHARMA INC AVBP | Novo Holdings A/S | 1,750,000 5.200% | 1,750,000 (New Position) | Filing History |
| 2025-01-16 9:43 pm Purchase | 2024-08-29 | 13D | GALECTO INC GLTO | Novo Holdings A/S | 99,913 7.600% | 1 (+0.00%) | Filing History |